Sign Out
Click on icon to see table/diagram/imagePost-marketing experience: The following events have also been reported during the post-marketing period. These events are reported voluntarily from a population of uncertain size, therefore it is not possible to reliably estimate their frequency.
Vision disorders: blurred vision, vision impairment.
During cataract and glaucoma surgery a small pupil situation, known as Intraoperative Floppy Iris Syndrome (IFIS), has been reported during post-marketing surveillance (see also Precautions).
Skin and subcutaneous tissue disorders: dermatitis exfoliative, erythema multiforme, photosensitivity reaction.
Respiratory, thoracic and mediastinal disorders: epistaxis.
In addition to the adverse events listed previously, atrial fibrillation, arrhythmia, tachycardia and dyspnoea have been reported in association with tamsulosin use. However, the role of tamsulosin in their causation cannot be reliably determined.
View ADR Monitoring Form
